39 Dossenbach MRK, Beuzen JN, Avnon M, et al. The effectiveness of olanzapine in treatment-refractory schizophrenia when patients are nonresponsive to or unable to tolerate clozapine. Clin Ther 2000; 22:1021-1034.
40Lokshin P, Dorfman P, Shoshani D, et al. Olanzapine treatment after clozapine induced agranulocytosis. Human Psychopharmacol 1998; 13:583-584.
41 Onofrj M, Thomas A, Paci C, et al. Olanzapine safely administered in three senile psychotic Parkinson's disease previously affected by clozapine induced granulocytopenia. Journal Neural Transm 1999; 106:XXVIII.
42 Swartz JR, Ananth J, Smith MW, , et al. Olanzapine treatment after clozapine-induced granulocytopenia in 3 patients. J Clin Psychiatry 1999; 60:119-121.
43 Weiss EL, Longhurst JG, Bowers MB, Jr., Mazure CM. Olanzapine for treatment-refractory psychosis in patients responsive to, but intolerant of, clozapine. J Clin Psychopharmacol 1999; 19:378-380.
44 Oyewumi LK, Al Semaan Y. Olanzapine: safe during clozapine-induced agranulocytosis. J Clin Psychopharmacol 2000; 20:279-281.
45 Hummer M, Kurz M, Barnas C, et al. Clozapine-induced transient white blood count disorders. J Clin Psychiatry 1994; 55:429-432.
46 Purdon SE, Malla A, Labelle A, Lit W. Neuropsychological change in patients with schizophrenia after treatment with quetiapine or haloperidol. J Psychiatry Neurosci 2001; 26:137-149.
47 Copolov DL, Link CG, Kowalcyk B. A multicentre, double-blind, randomized comparison of quetiapine (ICI 204,636, 'Seroquel') and haloperidol in schizophrenia. Psychol Med 2000; 30:95-105.
48 Emsley RA, Raniwalla J, Bailey PJ, Jones AM. A comparison of the effects of uetiapine ('seroquel') and haloperidol in schizophrenic patients with a history of and a demonstrated, partial response to conventional antipsychotic treatment. PRIZE Study Group. Int Clin Psychopharmacol 2000; 15:121-131.
49 Mullen J, Jibson MD, Sweitzer D. A comparison of the relative safety, efficacy, and tolerability of quetiapine and risperidone in outpatients with schizophrenia and other psychotic disorders: the quetiapine experience with safety and tolerability (QUEST) study. Clin Ther 2001; 23:1839-1854.
50 Quetiapine offers promise for difficult-to-treat psychosis complicating Parkinson's disease. Drugs and Therapy Perspectives 2001; 17:1-5.